Featuring perspectives from Dr Dana M Chase, Ms Sarah Karpen, Dr J Alejandro Rauh-Hain and Ms Jaclyn Shaver, moderated by Dr Chase, including the following topics:

• Introduction: Biology of Endometrial Cancer (EC) (0:00)
• First-Line Therapy for Advanced or Recurrent EC (14:15)
• Potential Benefits of PARP Inhibition Combined with Immunotherapy in Advanced EC (35:13)
• Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced EC (57:48)
• Other Nursing Considerations in the Care of Patients with Advanced EC (1:17:28)

NCPD information and select publications